𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro and in vivo release of gentamicin from biodegradable discs

✍ Scribed by Pavan Kumar Naraharisetti; Herman Chian Guan Lee; Yin-Chih Fu; Duu-Jong Lee; Chi-Hwa Wang

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
257 KB
Volume
77B
Category
Article
ISSN
1552-4973

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Osteomyelitis is an infection of the bone and successful treatment involves the removal of the affected bone and the tissue by a surgical procedure following prolonged systemic and local antibiotic therapy for 4 to 6 weeks. The current local treatment is done by poly methyl methacrylate (PMMA) beads loaded with gentamicin and PMMA, being nondegradable, is to be removed by a second surgical procedure. The current study aims to develop a biodegradable composition that gives sustained release and hence reducing the need for a second surgery. Gentamicin‐loaded discs were produced by compressing microparticle–gentamicin mixture obtained by spray drying a mixture of gentamicin in a solution of a biodegradable polymer. Different copolymers of poly (DL‐lactic‐co‐glycolic acid) (PLGA) were used to study the effect of copolymer ratio and the hydrophilic–hydrophobic nature of the polymer. Theoretical drug loading up to 25% were studied and it was observed that 10% drug loading was optimum for gentamicin to be used as solid in spray drying. The results showed that about 60% of the drug is released in about 5 to 6 days and the remaining drug is released in about 30 days in total. An in vivo study was carried on rabbit femur and the local area and systemic concentration of gentamicin was monitored. It was observed that the local area concentration of gentamicin was above minimum inhibitory concentration for more than 20 days and this was also validated by computer simulations. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006

📜 SIMILAR VOLUMES

In vivo release of vancomycin from biode
In vivo release of vancomycin from biodegradable beads
✍ Liu, Shih-Jung ;Wen-Neng Ueng, Steve ;Lin, Song-Shu ;Chan, Err-Cheng 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract The current delivery system of antibiotics for the treatment of osteomyelitis uses polymethylmethacrylate (PMMA) beads as a local drug‐release agent. The nonbiodegradable nature of the PMMA, however, necessitates a second operation to remove the beads. This article explores the alternat

Release of gentamicin from bone regenera
Release of gentamicin from bone regenerative materials: An in vitro study
✍ M. Teller; U. Gopp; H.-G. Neumann; K.-D. Kühn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB

## Abstract Antibiotic loading of bone regenerative materials is a promising way to protect augmentation procedures from infection during the resorption phase of bone substitutes. Especially in the early stage of implantation, it should protect the grafted site against microbiological pathogens. Th

Controlled release of EGF and bFGF from
Controlled release of EGF and bFGF from dextran hydrogels in vitro and in vivo
✍ Alper K. Doǧan; Menemşe Gümüşderelioǧlu; Erol Aksöz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

## Abstract In the present study, dextran‐epichlorohydrin hydrogels were employed as carriers for the controlled release of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF). The hydrogels were synthesized from 50% (by weight) monomeric cross‐linker, epichlorohydrin, containin